TY - JOUR TI - International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV AU - Singer, S. AU - Amdal, C.D. AU - Hammerlid, E. AU - Tomaszewska, I.M. AU - Castro Silva, J. AU - Mehanna, H. AU - Santos, M. AU - Inhestern, J. AU - Brannan, C. AU - Yarom, N. AU - Fullerton, A. AU - Pinto, M. AU - Arraras, J.I. AU - Kiyota, N. AU - Bonomo, P. AU - Sherman, A.C. AU - Baumann, I. AU - Galalae, R. AU - Fernandez Gonzalez, L. AU - Nicolatou-Galitis, O. AU - Abdel-Hafeez, Z. AU - Raber-Durlacher, J. AU - Schmalz, C. AU - Zotti, P. AU - Boehm, A. AU - Hofmeister, D. AU - Krejovic Trivic, S. AU - Loo, S. AU - Chie, W.-C. AU - Bjordal, K. AU - Brokstad Herlofson, B. AU - Grégoire, V. AU - Licitra, L. AU - on behalf of the EORTC Quality of Life AU - the EORTC Head AU - Neck Cancer Groups JO - Head and Neck Oncology PY - 2019 VL - 41 TODO - 6 SP - 1725-1737 PB - John Wiley and Sons Inc SN - null TODO - 10.1002/hed.25609 TODO - aged; clinical trial; complication; Europe; female; head and neck tumor; human; male; middle aged; multimodality cancer therapy; phase 4 clinical trial; prospective study; psychology; psychometry; quality of life; questionnaire; reproducibility; sensitivity and specificity; very elderly, Aged; Aged, 80 and over; Combined Modality Therapy; Europe; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Psychometrics; Quality of Life; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires TODO - Background: We validated the new European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43). Methods: We enrolled 812 patients with head and neck cancer from 18 countries. Group 1 completed the questionnaire before therapy, and 3 and 6 months later. In group 2 (survivors), we determined test–retest reliability using intraclass correlation coefficients (ICC). Internal consistency was assessed using Cronbach's Alpha, the scale structure with confirmatory factor analysis, and discriminant validity with known-group comparisons. Results: Cronbach's alpha was >0.70 in 10 of the 12 multi-item scales. All standardized factor loadings exceeded 0.40. The ICC was >0.70 in all but two scales. Differences in scale scores between known-groups were >10 points in 17 of the 19 scales. Sensitivity to change was found to be sufficient in 18 scales. Conclusions: Evidence supports the reliability and validity of the EORTC QLQ-HN43 as a measure of quality of life. © 2019 Wiley Periodicals, Inc. ER -